Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials - PubMed (original) (raw)
Review
Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials
Dariush Mozaffarian et al. PLoS Med. 2010.
Abstract
Background: Reduced saturated fat (SFA) consumption is recommended to reduce coronary heart disease (CHD), but there is an absence of strong supporting evidence from randomized controlled trials (RCTs) of clinical CHD events and few guidelines focus on any specific replacement nutrient. Additionally, some public health groups recommend lowering or limiting polyunsaturated fat (PUFA) consumption, a major potential replacement for SFA.
Methods and findings: We systematically investigated and quantified the effects of increased PUFA consumption, as a replacement for SFA, on CHD endpoints in RCTs. RCTs were identified by systematic searches of multiple online databases through June 2009, grey literature sources, hand-searching related articles and citations, and direct contacts with experts to identify potentially unpublished trials. Studies were included if they randomized participants to increased PUFA for at least 1 year without major concomitant interventions, had an appropriate control group, and reported incidence of CHD (myocardial infarction and/or cardiac death). Inclusions/exclusions were adjudicated and data were extracted independently and in duplicate by two investigators and included population characteristics, control and intervention diets, follow-up duration, types of events, risk ratios, and SEs. Pooled effects were calculated using inverse-variance-weighted random effects meta-analysis. From 346 identified abstracts, eight trials met inclusion criteria, totaling 13,614 participants with 1,042 CHD events. Average weighted PUFA consumption was 14.9% energy (range 8.0%-20.7%) in intervention groups versus 5.0% energy (range 4.0%-6.4%) in controls. The overall pooled risk reduction was 19% (RR = 0.81, 95% confidence interval [CI] 0.70-0.95, p = 0.008), corresponding to 10% reduced CHD risk (RR = 0.90, 95% CI = 0.83-0.97) for each 5% energy of increased PUFA, without evidence for statistical heterogeneity (Q-statistic p = 0.13; I(2) = 37%). Meta-regression identified study duration as an independent determinant of risk reduction (p = 0.017), with studies of longer duration showing greater benefits.
Conclusions: These findings provide evidence that consuming PUFA in place of SFA reduces CHD events in RCTs. This suggests that rather than trying to lower PUFA consumption, a shift toward greater population PUFA consumption in place of SFA would significantly reduce rates of CHD. Please see later in the article for the Editors' Summary.
Conflict of interest statement
DM: Research grants to study the effects of dietary factors on cardiovascular diseases from the US National Institutes of Health; the Searle Scholar Award from the Searle Funds at The Chicago Community Trust; the Genes and Environment Initiative at the Harvard School of Public Health; the Gates Foundation/World Health Organization Global Burden of Diseases, Injuries, and Risk Factors Study; and GlaxoSmithKline, Sigma Tau, and Pronova for an investigator-initiated trial of fish oil to prevent post-surgical arrhythmia. Honoraria and travel expenses for speaking at scientific conferences and reviewing on topics related to diet and cardiovascular disease, including from the U.S. Food and Drug Administration, International Life Sciences Institute, Aramark, Unilever, SPRIM, Nutrition Impact, World Health Organization, UpToDate, and several universities and scientific organizations. No ownership, patents, stocks, advisory board membership, nor speaking board membership. RM, SW: No disclosures.
Figures
Comment in
Similar articles
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article. - Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Hooper L, et al. Cochrane Database Syst Rev. 2020 Aug 21;8(8):CD011737. doi: 10.1002/14651858.CD011737.pub3. Cochrane Database Syst Rev. 2020. PMID: 32827219 Free PMC article. - Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Abdelhamid A, Davey Smith G. Hooper L, et al. Cochrane Database Syst Rev. 2015 Jun 10;(6):CD011737. doi: 10.1002/14651858.CD011737. Cochrane Database Syst Rev. 2015. PMID: 26068959 Updated. Review. - Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS, Martin N, Bridges C, Brainard JS, Wang X, Brown TJ, Hanson S, Jimoh OF, Ajabnoor SM, Deane KH, Song F, Hooper L. Abdelhamid AS, et al. Cochrane Database Syst Rev. 2018 Nov 27;11(11):CD012345. doi: 10.1002/14651858.CD012345.pub3. Cochrane Database Syst Rev. 2018. PMID: 30484282 Free PMC article.
Cited by
- Beneficial effects of linoleic acid on cardiometabolic health: an update.
Jackson KH, Harris WS, Belury MA, Kris-Etherton PM, Calder PC. Jackson KH, et al. Lipids Health Dis. 2024 Sep 12;23(1):296. doi: 10.1186/s12944-024-02246-2. Lipids Health Dis. 2024. PMID: 39267068 Free PMC article. Review. - Can Omega-3 prevent the accidence of stroke: a mendelian randomization study.
Xi C, Zhang J, Liu H, Tao S, Xie Y, Liu J, Tong C, Tian D, Ye H, Zhang X. Xi C, et al. Hereditas. 2024 Sep 5;161(1):30. doi: 10.1186/s41065-024-00329-9. Hereditas. 2024. PMID: 39232799 Free PMC article. - Effects of full-fat high-oleic soybean meal in layer diets on performance, egg quality and chemical composition.
Toomer OT, Maharjan P, Harding KL, Chuong Vu T, Malheiros R, Mian R, Joseph M, Read QD, Oviedo-Rondon EO, Anderson KE. Toomer OT, et al. Poult Sci. 2024 Oct;103(10):104074. doi: 10.1016/j.psj.2024.104074. Epub 2024 Jul 15. Poult Sci. 2024. PMID: 39098299 Free PMC article. - ONE QUALITY concept: a narrative perspective to unravel nutritional challenges, controversies, and the imperative need of transforming our food systems.
Menta R, Rosso G, Canzoneri F. Menta R, et al. Front Nutr. 2024 Apr 15;11:1379159. doi: 10.3389/fnut.2024.1379159. eCollection 2024. Front Nutr. 2024. PMID: 38685955 Free PMC article. - Dairy Matrix Effects: Physicochemical Properties Underlying a Multifaceted Paradigm.
Huppertz T, Shkembi B, Brader L, Geurts J. Huppertz T, et al. Nutrients. 2024 Mar 25;16(7):943. doi: 10.3390/nu16070943. Nutrients. 2024. PMID: 38612977 Free PMC article. Review.
References
- Dayton S, Pearce ML, Goldman H, Harnish A, Plotkin D, et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet. 1968;2:1060–1062. - PubMed
- Medical Research Council. Controlled trial of soya-bean oil in myocardial infarction. Lancet. 1968;2:693–699. - PubMed
- Leren P. The Oslo diet-heart study. Eleven-year report. Circulation. 1970;42:935–942. - PubMed
- Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, et al. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol. 1979;8:99–118. - PubMed
- Miettinen M, Turpeinen O, Karvonen MJ, Pekkarinen M, Paavilainen E, et al. Dietary prevention of coronary heart disease in women: the Finnish mental hospital study. Int J Epidemiol. 1983;12:17–25. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous